Patents Assigned to CoraMed Healthcare, Inc.
  • Method of evaluating patient hemostasis
    Patent number: 7732213
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of a patient hemostasis condition.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: June 8, 2010
    Assignee: CoraMed Healthcare, Inc.
    Inventors: Eli Cohen, Roslyn Cohen
  • Protocol For Risk Stratification of Ischemic Events and Optimized Individulaized Treatment
    Publication number: 20090112483
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject.
    Type: Application
    Filed: December 31, 2008
    Publication date: April 30, 2009
    Applicant: CORAMED HEALTHCARE, INC.
    Inventor: Eli Cohen